a 25-year - old male patient was admitted to the hospital 's hematology ward with the diagnosis of acute lymphocytic leukemia .
the effects are fully reversible after a few months once the causative agent has been withdrawn   .
the number of patients undergoing chemotherapy grows year by year . despite their efficacy in controlling the cancer , chemotherapy drugs are not inert , and they cause damage to the human body
the most common chemotherapeutic agents implicated in nail changes are cyclophosphamide , doxorubicin and hydroxyurea   . in the majority of cases ,
ungual hyperpigmentation induced by chemotherapy is not uncommon , although its occurrence is underestimated and seldom reported , especially in patients with dark skin phototypes , such as our patient , in this case , the drugs most probably implicated are doxorubicin and cyclophosphamide because they produce ungual alterations very similar to the ones seen in our patient ; his chemotherapeutic scheme included both of them .
regarding nail involvement , diverse clinical features can be observed , according to the structure affected and the severity of the damage caused .
the hyper - cvad regimen delivers a combination of drugs in 2 cycles ( cyclophosphamide , vincristine , doxorubicin and dexamethasone in cycle a , methotrexate and cytarabine in cycle b ) , split into smaller doses and administered at more frequent intervals in order to minimize side effects . during hospitalization , a dermatology assessment was requested .